Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$245K Sell
1,673
-63
-4% -$11.4K 0.03% 91
2026
Q1
$255K Buy
1,736
+122
+8% +$19.8K 0.04% 82
2025
Q4
$315K Sell
1,614
-194
-11% -$46.2K 0.04% 78
2025
Q3
$508K Buy
1,808
+7
+0.4% +$1.78K 0.08% 63
2025
Q2
$394K Buy
1,801
+2
+0.1% +$323 0.06% 69
2025
Q1
$252K Buy
1,799
+3
+0.2% +$488 0.04% 80
2024
Q4
$299K Hold
1,796
0.05% 76
2024
Q3
$306K Hold
1,796
0.06% 77
2024
Q2
$254K Hold
1,796
0.05% 80
2024
Q1
$226K Buy
+1,796
New +$206K 0.05% 85
2023
Q3
Sell
-1,796
Closed -$214K 99
2023
Q2
$214K Buy
+1,796
New +$186K 0.05% 95
2021
Q2
Sell
-1,178
Closed -$83K 234
2021
Q1
$83K Sell
1,178
-737
-38% -$47.7K 0.02% 141
2020
Q4
$124K Sell
1,915
-46
-2% -$2.74K 0.04% 125
2020
Q3
$117K Buy
1,961
+61
+3% +$3.46K 0.04% 117
2020
Q2
$105K Hold
1,900
0.04% 126
2020
Q1
$92K Sell
1,900
-323
-15% -$16.7K 0.04% 119
2019
Q4
$118K Buy
2,223
+323
+17% +$17.8K 0.04% 146
2019
Q3
$105K Buy
1,900
+116
+7% +$6.41K 0.04% 141
2019
Q2
$102K Buy
+1,784
New +$96.5K 0.04% 155

Other funds holding ORCL

Human Investing's ORCL Position: Q2 2026 in Review

Human Investing reduced its Oracle (ORCL) stake by 3.6% in Q2 2026, selling an estimated $11.4K and leaving 1,673 shares worth $245K. The position accounts for 0.03% of the portfolio, ranked #91.

Human Investing first reported a position in ORCL in Q2 2019 and has held it in 19 quarters since. The position peaked at $508K in Q3 2025. 1,585 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Human Investing held 1,673 shares of Oracle worth $245K as of Q2 2026.
  • Human Investing sold 63 Oracle shares in Q2 2026, an estimated $11.4K.
  • Oracle made up 0.03% of Human Investing's portfolio in Q2 2026, its #91 holding.
  • Human Investing first reported a position in Oracle in Q2 2019 and has held it in 19 quarters since.
  • Human Investing's Oracle position peaked at $508K in Q3 2025.
  • 1,585 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Human Investing's 13F filing for Q2 2026, filed 20 Jul 2026.